<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>12236938</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Vidaller Palacín, A</dc:author>
<dc:author>Shaw Perujo, E</dc:author>
<dc:author>Fernández-Sabé, N</dc:author>
<dc:author>Pujol Farriols, R</dc:author>
<dc:author>Jato De Evan, M</dc:author>
<dc:author>Moga Sampere, I</dc:author>
<dc:author>Rubio Borrego, F</dc:author>
<dc:description xml:lang="en">OBJECTIVE To report the prevalence of acute cerebrovascular accidents (ACVA) and risk factors for thrombosis among patients diagnosed of primary antiphospholipid syndrome (PAPLS) and to compare this group with that of patients with PAPLS but not ACVA. PATIENTS AND METHODS Retrospective data analysis of 30 patients consecutively diagnosed of PAPLS. Episodes of ACVA were quantitated and other cardiovascular risk factors were determined. RESULTS Thirty percent of patients (9/30) had one or more ACVA. No significant differences were found when the presence of other cardiovascular risk factors in both groups was compared. CONCLUSIONS Antiphospholipid antibodies in young patients with ACVA should be determined, although some other cardiovascular risk factors may coexist.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2002 Sep </dc:date>
<dc:title xml:lang="es">Accidente cerebrovascular agudo en el síndrome antifosfolipídico primario.</dc:title>
<dc:title xml:lang="en">[Acute cerebrovascular accident in the primary antiphospholipid syndrome].</dc:title>
<dc:publisher>Revista clinica espanola</dc:publisher>
</metadata>
</record>
</pubmed-document>
